SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-106959
Filing Date
2024-04-23
Accepted
2024-04-23 16:02:01
Documents
9
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d240250ddef14a.htm DEF 14A 381292
2 GRAPHIC g240250dsp041.jpg GRAPHIC 4005
3 GRAPHIC g240250dsp041a.jpg GRAPHIC 2087
4 GRAPHIC g240250g00r78.jpg GRAPHIC 29822
5 GRAPHIC g240250g16m01.jpg GRAPHIC 20032
6 GRAPHIC g240250g16m02.jpg GRAPHIC 47281
7 GRAPHIC g240250g16m03.jpg GRAPHIC 44875
8 GRAPHIC g240250g33m01.jpg GRAPHIC 81398
9 GRAPHIC g240250g33m03.jpg GRAPHIC 80568
  Complete submission text file 0001193125-24-106959.txt   808707
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35890 | Film No.: 24864766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)